Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33997
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTaylor, Kieran-
dc.contributor.authorDe Bruyne, Mihika-
dc.contributor.authorLi, Christine-
dc.contributor.authorYip, Marcus-
dc.contributor.authorGrant, Dominique-
dc.contributor.authorTang, Xinci-
dc.contributor.authorLaing, Sarah-
dc.contributor.authorPreston, Braden-
dc.contributor.authorChand, Kavinay-
dc.contributor.authorDe Silva, Anurika-
dc.contributor.authorLeslie, Kate-
dc.contributor.authorDarvall, Jai N-
dc.date2023-
dc.date.accessioned2023-10-18T03:29:31Z-
dc.date.available2023-10-18T03:29:31Z-
dc.date.issued2023-12-
dc.identifier.citationBJA Open 2023-12; 8en_US
dc.identifier.issn2772-6096-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/33997-
dc.description.abstractThe Apfel simplified risk score includes four risk factors: female sex, non-smoking status, postoperative nausea and vomiting or motion sickness history, and postoperative opioid use. The score is calculated preoperatively, so postoperative opioid use must be predicted. We aimed to determine whether anaesthetists can predict patients' postoperative opioid use and dose. Specialist anaesthetists from eight hospitals preoperatively predicted opioid use and dose in the post-anaesthesia care unit (PACU) and for the first 24 h postoperatively, which was compared with actual opioid use and dose. Opioid doses were converted to oral morphine equivalents (MEQ). Correlations between predicted and actual opioid use and dose were analysed with Spearman's rho and linear regression. A total of 487 anaesthetist-patient pairs were included. Anaesthetists overpredicted opioid use (398 [82%] predicted vs 251 [52%] actual patients requiring opioids in the PACU; 396 [81%] predicted vs 291 [60%] actual in the first 24 h) (Spearman's rho [95% confidence interval] 0.24 [0.16-0.33], P<0.001 in the PACU; 0.36 [0.28-0.44], P<0.001 in the first 24 h). Anaesthetists also overpredicted opioid dose (median [inter-quartile range] 12 [8-20] mg predicted MEQ vs 4 [0-18] mg actual MEQ in the PACU; 32 [18-60] mg vs 24 [0-65] mg MEQ in the first 24 h) (Spearman's rho 0.21 [0.13-0.29], P<0.001 in the PACU; 0.53 [0.40-0.60], P<0.001 in the first 24 h). Specialist anaesthetists cannot accurately predict opioid use or dose in the PACU or the first 24 postoperative hours. The Apfel risk criterion for postoperative opioid use may be inaccurate in clinical practice.en_US
dc.language.isoeng-
dc.subjectanaesthesiaen_US
dc.subjectopioiden_US
dc.subjectpostoperative nausea and vomitingen_US
dc.subjectrisk predictionen_US
dc.subjectrisk scoreen_US
dc.titleAnaesthetist prediction of postoperative opioid use: a multicentre prospective cohort study.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleBJA Openen_US
dc.identifier.affiliationDepartment of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Australia.;School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Australia.;School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Anaesthesia and Pain Medicine, Footscray Hospital, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Anaesthesia, St Vincent's Hospital, Melbourne, Australia.en_US
dc.identifier.affiliationAnaesthesiaen_US
dc.identifier.affiliationDepartment of Anaesthesia, Northern Hospital, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Anaesthesia, Ballarat Base Hospital, Ballarat, Australia.en_US
dc.identifier.affiliationDepartment of Anaesthesia, Northeast Health Wangaratta, Wangaratta, Australia.en_US
dc.identifier.affiliationDepartment of Anaesthesia, Goulburn Valley Health, Shepparton, Australia.en_US
dc.identifier.affiliationCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Monash University, Melbourne, Australia.;Methods and Implementation Support for Clinical and Health Research Hub, Faculty of Medicine, Dentistry and Health Sciences, Monash University, Melbourne, Australia.en_US
dc.identifier.affiliationCentral Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.;Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Australia.;Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Australia.en_US
dc.identifier.doi10.1016/j.bjao.2023.100226en_US
dc.type.contentTexten_US
dc.identifier.pubmedid37830104-
dc.description.volume8-
dc.description.startpage100226-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

24
checked on Nov 3, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.